SCHEMBL2723744

SCHEMBL2723744

O=C(c1ccc(-c2ccc(CC3CCN(C4CCCCC4)C3=O)c(C(F)(F)F)c2)cc1)N1CCS(=O)(=O)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.40
ERN1 O75460 1/20 0.35
HDAC4 P56524 3/20 0.35
SLC9A1 P19634 1/20 0.35
ABL1 P00519 1/20 0.35
BCR P11274 1/20 0.35
HPGD P15428 2/20 0.34
MEN1 O00255 1/20 0.34
TSHR P16473 1/20 0.34
KMT2A Q03164 1/20 0.34
JAK2 O60674 1/20 0.34
JAK1 P23458 1/20 0.34
MBTD1 Q05BQ5 1/20 0.34
L3MBTL3 Q96JM7 1/20 0.34
CNR2 P34972 1/20 0.34
ALK Q9UM73 2/20 0.34
PIK3CD O00329 1/20 0.34
FASN P49327 1/20 0.33
P2RX7 Q99572 1/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL209678 0.90 HDAC4 (0.42) HSD11B1HDAC4ABL1BCRHPGD
SCHEMBL208962 0.89 KCNH2 (0.42) HSD11B1ERN1ABL1BCRALK
SCHEMBL207094 0.89 HSD11B1 (0.41) HSD11B1ERN1HDAC4SLC9A1ABL1
SCHEMBL209360 0.87 HSD11B1 (0.38) HSD11B1HPGDJAK2JAK1MBTD1
Trifluoroacetic Acid SCHEMBL15204212 0.87 POLB (0.41) HSD11B1HDAC4ABL1HPGDL3MBTL3
SCHEMBL208882 0.87 HSD11B1 (0.39) HSD11B1ERN1HDAC4SLC9A1ABL1
SCHEMBL209025 0.86 HSD11B1 (0.39) HSD11B1ERN1HDAC4ABL1BCR
Trifluoroacetic Acid SCHEMBL15204302 0.86 RAD52 (0.42) HSD11B1SLC9A1ABL1BCRALK
Trifluoroacetic Acid SCHEMBL15204207 0.86 HSD11B1 (0.40) HSD11B1ERN1HDAC4SLC9A1MBTD1
SCHEMBL209346 0.85 HSD11B1 (0.48) HSD11B1ALKP2RX7ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2016047-B1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11- BETA-HYDROXYSTEROID DEHYDROGENASE 1 LILLY CO ELI (US) 2013-08-28 EP disclosed
US-8088776-B2 Biphenyl amide lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 ELI LILLY AND COMPANY (US) 2012-01-03 US disclosed
US-8088776-B2 Biphenyl amide lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 ELI LILLY AND COMPANY (US) 2012-01-03 US disclosed
US-20090156571-A1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY 2009-06-18 US disclosed
US-20090156571-A1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY 2009-06-18 US disclosed
WO-2007124337-A1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11- BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY (US) 2007-11-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156571-A1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 HSD11B1, HSD17B1, HSD11B2 HSD11B1 1/4885ERN1 1347/4885HDAC4 1077/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.